VCYT vs CDNA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CDNA Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CareDx, Inc. (CDNA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while VCYT counters with relative strength in Valuation. Fundamentally, VCYT trades at 15.3x Forward P/E with 15.0% operating margin (+15.1% YoY revenue) versus CDNA at 47.1x Forward P/E and 1.6% operating margin (+39.3% YoY). In options structure, VCYT sits in BREAKDOWN (47th %ile IV; Dealer Gamma Walls on Pro) against CDNA sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VCYT Revenue | CDNA Revenue | VCYT Op. Margin | CDNA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $90M | $80M | -24.2% | -20.3% | CDNA |
| FY2019 | $120M | $130M | -12.6% | -19.3% | VCYT |
| FY2020 | $120M | $190M | -30.1% | -11.7% | CDNA |
| FY2021 | $220M | $300M | -37.3% | -10.0% | CDNA |
| FY2022 | $300M | $320M | -13.9% | -24.0% | VCYT |
| FY2023 | $360M | $280M | -23.8% | -72.5% | VCYT |
| FY2024 | $450M | $330M | 3.6% | 12.2% | CDNA |
| FY2025 | $520M | $380M | 11.2% | -8.1% | VCYT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VCYT | CDNA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.0B | $4.1B | Larger Scale | CDNA |
| Trailing P/E Ratio Valuation | 15.8x | 32.9x | Lower Multiple | VCYT |
| Forward P/E Ratio Valuation | 15.3x | 47.1x | Lower Multiple | VCYT |
| Revenue Growth (YoY) Growth | +15.1% | +39.3% | Higher Growth | CDNA |
| Operating Margin (TTM) Profitability | 15.0% | 1.6% | Higher Margin | VCYT |
| Net Profit Margin Profitability | 21.8% | 25.9% | Higher Margin | CDNA |
| Return on Equity (ROE) Capital Efficiency | 9.4% | 33.0% | Higher ROE | CDNA |
| 52-Week Range Position Momentum | 5% ($22โ$61) | 77% ($15โ$91) | Stronger Trend | CDNA |
| Beta / 30D Volatility Risk Regime | 3.01ฮฒ ยท 199% Vol | 1.21ฮฒ ยท 98% Vol | Lower Realized Risk | CDNA |
| Unified Institutional Score Composite Signal | 49.1 / 100 (HOLD) | 24.5 / 100 (STRONG SELL) | Higher Composite | VCYT |